These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 33503867)

  • 21. Chemokines and their receptors in Atherosclerosis.
    van der Vorst EP; Döring Y; Weber C
    J Mol Med (Berl); 2015 Sep; 93(9):963-71. PubMed ID: 26175090
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Porphyromonas gingivalis lipopolysaccharide alters atherosclerotic-related gene expression in oxidized low-density-lipoprotein-induced macrophages and foam cells.
    Lei L; Li H; Yan F; Li Y; Xiao Y
    J Periodontal Res; 2011 Aug; 46(4):427-37. PubMed ID: 21418223
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chemokines: inflammatory mediators of atherosclerosis.
    Liehn EA; Zernecke A; Postea O; Weber C
    Arch Physiol Biochem; 2006; 112(4-5):229-38. PubMed ID: 17178596
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chemokines in liver inflammation and fibrosis.
    Wasmuth HE; Tacke F; Trautwein C
    Semin Liver Dis; 2010 Aug; 30(3):215-25. PubMed ID: 20665374
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Atypical Chemokine Receptors in Cardiovascular Disease.
    Gencer S; van der Vorst EPC; Aslani M; Weber C; Döring Y; Duchene J
    Thromb Haemost; 2019 Apr; 119(4):534-541. PubMed ID: 30716778
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Leukocyte influx in atherosclerosis.
    Galkina E; Ley K
    Curr Drug Targets; 2007 Dec; 8(12):1239-48. PubMed ID: 18220701
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The fine balance of chemokines during disease: trafficking, inflammation, and homeostasis.
    Cardona SM; Garcia JA; Cardona AE
    Methods Mol Biol; 2013; 1013():1-16. PubMed ID: 23625489
    [TBL] [Abstract][Full Text] [Related]  

  • 28. IgE Contributes to Atherosclerosis and Obesity by Affecting Macrophage Polarization, Macrophage Protein Network, and Foam Cell Formation.
    Zhang X; Li J; Luo S; Wang M; Huang Q; Deng Z; de Febbo C; Daoui A; Liew PX; Sukhova GK; Metso J; Jauhiainen M; Shi GP; Guo J
    Arterioscler Thromb Vasc Biol; 2020 Mar; 40(3):597-610. PubMed ID: 31996021
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Vascular Endothelial Growth Factor Inhibitors Ranibizumab and Aflibercept Markedly Increase Expression of Atherosclerosis-Associated Inflammatory Mediators on Vascular Endothelial Cells.
    Arnott C; Punnia-Moorthy G; Tan J; Sadeghipour S; Bursill C; Patel S
    PLoS One; 2016; 11(3):e0150688. PubMed ID: 26959822
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chemokines in atherosclerosis: an update.
    Zernecke A; Shagdarsuren E; Weber C
    Arterioscler Thromb Vasc Biol; 2008 Nov; 28(11):1897-908. PubMed ID: 18566299
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeting foam cell formation and macrophage polarization in atherosclerosis: The Therapeutic potential of rhubarb.
    Liu X; Wu J; Tian R; Su S; Deng S; Meng X
    Biomed Pharmacother; 2020 Sep; 129():110433. PubMed ID: 32768936
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Atherosclerosis-underlying inflammatory mechanisms and clinical implications.
    Patel S; Celermajer DS; Bao S
    Int J Biochem Cell Biol; 2008; 40(4):576-80. PubMed ID: 18203647
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Simvastatin modulates chemokine and chemokine receptor expression by geranylgeranyl isoprenoid pathway in human endothelial cells and macrophages.
    Veillard NR; Braunersreuther V; Arnaud C; Burger F; Pelli G; Steffens S; Mach F
    Atherosclerosis; 2006 Sep; 188(1):51-8. PubMed ID: 16321392
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chemokines in oral inflammatory diseases: apical periodontitis and periodontal disease.
    Silva TA; Garlet GP; Fukada SY; Silva JS; Cunha FQ
    J Dent Res; 2007 Apr; 86(4):306-19. PubMed ID: 17384024
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Platelet-derived chemokines in inflammation and atherosclerosis.
    Bakogiannis C; Sachse M; Stamatelopoulos K; Stellos K
    Cytokine; 2019 Oct; 122():154157. PubMed ID: 29198385
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Atherogenic lipids induce adhesion of human coronary artery smooth muscle cells to macrophages by up-regulating chemokine CX3CL1 on smooth muscle cells in a TNFalpha-NFkappaB-dependent manner.
    Barlic J; Zhang Y; Murphy PM
    J Biol Chem; 2007 Jun; 282(26):19167-76. PubMed ID: 17456471
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Coagulation factor XII induces pro-inflammatory cytokine responses in macrophages and promotes atherosclerosis in mice.
    Vorlova S; Koch M; Manthey HD; Cochain C; Busch M; Chaudhari SM; Stegner D; Yepes M; Lorenz K; Nolte MW; Nieswandt B; Zernecke A
    Thromb Haemost; 2017 Jan; 117(1):176-187. PubMed ID: 27786338
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chemokines control mobilization, recruitment, and fate of monocytes in atherosclerosis.
    Drechsler M; Duchene J; Soehnlein O
    Arterioscler Thromb Vasc Biol; 2015 May; 35(5):1050-5. PubMed ID: 25792446
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting immune cell recruitment in atherosclerosis.
    Döring Y; van der Vorst EPC; Weber C
    Nat Rev Cardiol; 2024 Nov; 21(11):824-840. PubMed ID: 38664575
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fractalkine--a local inflammatory marker aggravating platelet activation at the vulnerable plaque.
    Flierl U; Schäfer A
    Thromb Haemost; 2012 Sep; 108(3):457-63. PubMed ID: 22739755
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.